Trial of the Impact of Sibeprenlimab on Immunoglobulin A Nephropathy Kidney Tissue
Clinical trial NCT06740526 · RECRUITING
Trial details
- NCT number
- NCT06740526
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-19
- Primary completion
- 2029-04-17
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.